Company Overview and News

1
Aben Mobilizes to Forrest Kerr Gold Project in BC’s Golden Triangle Region

2018-06-21 globenewswire
VANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) -- Aben Resources Ltd. (TSX-V:ABN) (OTCQB:ABNAF) (Frankfurt:E2L2) (the “Company”) is pleased to announce it has mobilized field-crews to its 23,000-hectare Forrest Kerr Gold Project located in BC’s Golden Triangle region to begin the Company’s 2018 summer exploration and field program. Aben is planning a 5000-metre diamond drilling program in approximately 18 drill holes at Forrest Kerr.
ABN GGIFF ABNAF GGI GTGDF

0
Kyba Hits the Red-Line Trail at Metallis’ Kirkham Property

2018-06-08 globenewswire
VANCOUVER, British Columbia, June 08, 2018 (GLOBE NEWSWIRE) -- Metallis Resources Inc. (TSX-V:MTS) (“Metallis” or the “Company”) is pleased to announce the launch of its Phase 1 2018 exploration program at its 100% owned Kirkham Property, prospective for multiple deposit types in the heart of Northwest British Columbia’s prolific Eskay Camp.
SA PVG GGIFF MTS GGI SEA PVG MTLFF

1
Aben Resources to Begin Forrest Kerr Drill Program in BC’s Golden Triangle Region

2018-05-23 globenewswire
VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- Aben Resources Ltd. (TSX-V:ABN) (OTC PINK:ABNAF) (Frankfurt:E2L2) (the “Company”) is pleased to announce plans for the upcoming summer drill program at the Forrest Kerr Gold Property located in Northwestern British Columbia’s Golden Triangle region. The Company is planning a 5000 metre diamond drill program commencing in mid-June.
ABN GGIFF ABNAF GGI GTGDF

0
Metallis & Talhtan Central Government Execute Communications Agreement

2018-05-15 globenewswire
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Metallis Resources Inc. (TSX-V:MTS) (“Metallis” or the “Company”) and Tahltan Central Government (“TCG”) are pleased to announce the signing of a Communications Agreement (the “Agreement”) covering the company’s 100% owned Kirkham Property located within the prolific Golden Triangle in BC's northwest.
SA PVG GGIFF MTS GGI SEA PVG MTLFF

0
Glacier Lake to Acquire Property in B.C.’s Prolific Golden Triangle

2018-04-18 globenewswire
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Glacier Lake Resources Inc. (TSXV:GLI) (“Glacier” or the “Company”) is pleased to announce that it has entered into an agreement to acquire the “Hackett” and the “North Wolverine” properties in the Sheslay area of northwestern British Columbia. The properties are located approximately 38 kilometers northwest of the village of Telegraph Creek, and approximately 95 kilometers west-southwest of Dease Lake.
GGIFF GGI AHR GLIIF DBV AXREF

0
Metallis Completes VTEM Survey & Provides Exploration Update on the Central Kirkham Area

2018-03-28 globenewswire
VANCOUVER, British Columbia, March 28, 2018 (GLOBE NEWSWIRE) -- Metallis Resources Inc. (TSX-V:MTS) (“Metallis” or the “Company”) announces that Geotech Ltd. has completed the 2018 airborne versatile time-domain electromagnetic survey (“VTEM Survey”) over its Thunder North, Thunder South and King areas within its 100% owned Kirkham Property. Click here for 2018 VTEM area block map.
SA PVG GGIFF MTS GGI SEA PVG MTLFF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to TSXV:GGI / Garibaldi Resources Corp on message board site Silicon Investor.

TGGI Strictly Bragging
Thugginu0027 u0026 A Bugginu0027 Adnan Kashoggi
SAFS (Safescience, Inc.) formerly IGGI. Hot Potential GGI / GGIT - GeoGraphics Inc.
Granite Golf Group, Inc. (GGGI-BB) Clinton -- doomed u0026 wagging, Japan collapses, Y2K bug, etc
ICED - Never Out of Ice! Automatic Ice-Making u0026 Bagging IGGI (IGG International)with 5.25Billion market?